Skip to main content
Erschienen in: International Urogynecology Journal 2/2011

01.02.2011 | Original Article

Is a dipstick test sufficient to exclude urinary tract infection in women with overactive bladder?

verfasst von: Elke Hessdoerfer, Katharina Jundt, Ursula Peschers

Erschienen in: International Urogynecology Journal | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

A dipstick test is recommended to screen for urinary tract infection in patients with overactive bladder (OAB). It was the aim of this study to test if a dipstick test is sufficient to identify patients with urinary tract infection attending a urological private practice because of OAB.

Methods

All patients who attended the practice because of OAB symptoms were routinely catheterized; a urine specimen was tested with dipstick, the spun sediment was examined microscopically, and the specimen was sent for microbiological examination.

Results

Two thousand two hundred fifty-two patients were examined. Of 1,754 patients with negative dipstick screening, 353 patients (20.1%) had growth of ≥103 colony forming units. The dipstick test had a sensitivity of 0.442 and a specificity of 0.865 for the correct identification of urinary tract infection.

Conclusions

Dipstick screening is not sufficient to identify patients with urinary tract infection and symptoms of OAB.
Literatur
1.
Zurück zum Zitat Abrams P, Cardozo L, Fall M, Griffiths DJ et al (2002) The standardisation of terminology of lower urinary tract function. Neurourol Urodyn 21:167–178CrossRefPubMed Abrams P, Cardozo L, Fall M, Griffiths DJ et al (2002) The standardisation of terminology of lower urinary tract function. Neurourol Urodyn 21:167–178CrossRefPubMed
2.
Zurück zum Zitat Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–336PubMed Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–336PubMed
3.
Zurück zum Zitat Staskin D, Hilton P, Emmanuel A et al (2005) Initial assessment of incontinence. In: Abrams P, Cardozo L, Khoury S, Wein A (eds) Incontinence. 3rd International Consultation on Incontinence. Health, Plymouth, pp 485–518 Staskin D, Hilton P, Emmanuel A et al (2005) Initial assessment of incontinence. In: Abrams P, Cardozo L, Khoury S, Wein A (eds) Incontinence. 3rd International Consultation on Incontinence. Health, Plymouth, pp 485–518
4.
Zurück zum Zitat Clinical and Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibility testing: 19th informational supplement. CLSI document M100-S19, 19th edn. Clinical and Laboratory Standards Institute, Wayne Clinical and Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibility testing: 19th informational supplement. CLSI document M100-S19, 19th edn. Clinical and Laboratory Standards Institute, Wayne
5.
Zurück zum Zitat Altman DG, Bland JM (1994) Diagnostic tests 2: predictive values. BMJ 309:102PubMed Altman DG, Bland JM (1994) Diagnostic tests 2: predictive values. BMJ 309:102PubMed
6.
Zurück zum Zitat Mitteness LS, Barker JC (1995) Stigmatizing a “normal” condition: urinary incontinence in late life. Med Anthropol Q 9:188–210CrossRefPubMed Mitteness LS, Barker JC (1995) Stigmatizing a “normal” condition: urinary incontinence in late life. Med Anthropol Q 9:188–210CrossRefPubMed
7.
Zurück zum Zitat Ward KL, Hilton P, Browning J, on behalf of the UK and Ireland TVT Trial Group (2000) A randomized trial of colposuspension and tension-free vaginal tape (TVT) for primary genuine stress incontinence. Neurourol Urodyn 20:386–389 Ward KL, Hilton P, Browning J, on behalf of the UK and Ireland TVT Trial Group (2000) A randomized trial of colposuspension and tension-free vaginal tape (TVT) for primary genuine stress incontinence. Neurourol Urodyn 20:386–389
8.
Zurück zum Zitat Reeves P, Irwin D, Kelleher C, Milsom I et al (2006) The current and future burden and cost of overactive bladder in five European countries. Eur Urol 50:1050–1057CrossRefPubMed Reeves P, Irwin D, Kelleher C, Milsom I et al (2006) The current and future burden and cost of overactive bladder in five European countries. Eur Urol 50:1050–1057CrossRefPubMed
9.
Zurück zum Zitat Buchsbaum GM, Albushies DT, Guzick DS (2004) Utility of urine reagent strip in screening women with incontinence for urinary tract infection. Int Urogynecol J Pelvic Floor Dysfunct 15:391–393CrossRefPubMed Buchsbaum GM, Albushies DT, Guzick DS (2004) Utility of urine reagent strip in screening women with incontinence for urinary tract infection. Int Urogynecol J Pelvic Floor Dysfunct 15:391–393CrossRefPubMed
10.
Zurück zum Zitat Sultana RV, Zalstein S, Cameron P, Campbell D (2001) Dipstick urinalysis and the accuracy of the clinical diagnosis of urinary tract infection. J Emerg Med 20:13–19CrossRefPubMed Sultana RV, Zalstein S, Cameron P, Campbell D (2001) Dipstick urinalysis and the accuracy of the clinical diagnosis of urinary tract infection. J Emerg Med 20:13–19CrossRefPubMed
11.
Zurück zum Zitat Al Daghistani HI, Abdel-Dayem M (2002) Diagnostic value of various urine tests in the Jordanian population with urinary tract infection. Clin Chem Lab Med 40:1048–1051CrossRefPubMed Al Daghistani HI, Abdel-Dayem M (2002) Diagnostic value of various urine tests in the Jordanian population with urinary tract infection. Clin Chem Lab Med 40:1048–1051CrossRefPubMed
12.
Zurück zum Zitat Semeniuk H, Church D (1999) Evaluation of the leukocyte esterase and nitrite urine dipstick screening tests for detection of bacteriuria in women with suspected uncomplicated urinary tract infections. J Clin Microbiol 37:3051–3052PubMed Semeniuk H, Church D (1999) Evaluation of the leukocyte esterase and nitrite urine dipstick screening tests for detection of bacteriuria in women with suspected uncomplicated urinary tract infections. J Clin Microbiol 37:3051–3052PubMed
13.
Zurück zum Zitat Gerber CS, Brendler CB (2002) Evaluation of the urologic patient: history, physical examination, and urinalysis. In: Campbell MF, Walsh PC, Retik AB (eds) Campbell’s Urology, 8th edn. Saunders, Philadelphia, pp 83–110 Gerber CS, Brendler CB (2002) Evaluation of the urologic patient: history, physical examination, and urinalysis. In: Campbell MF, Walsh PC, Retik AB (eds) Campbell’s Urology, 8th edn. Saunders, Philadelphia, pp 83–110
14.
Zurück zum Zitat National Institute for Health and Clinical Excellence (2006) Urinary incontinence: the management of urinary incontinence in women. NICE Guideline CG40 National Institute for Health and Clinical Excellence (2006) Urinary incontinence: the management of urinary incontinence in women. NICE Guideline CG40
Metadaten
Titel
Is a dipstick test sufficient to exclude urinary tract infection in women with overactive bladder?
verfasst von
Elke Hessdoerfer
Katharina Jundt
Ursula Peschers
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 2/2011
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-010-1263-5

Weitere Artikel der Ausgabe 2/2011

International Urogynecology Journal 2/2011 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.